Related Experiment Video
Updated: May 21, 2026

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles
Published on: March 18, 2015
Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN
Xinyu Zhang1, Shuzhao Jia, Shumeng Yang
1Department of Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
Abstract:
Arsenic trioxide (As(2)O(3)), an effective agent against acute promyelocytic leukemia, has been reported to inhibit the viability of solid tumors cell lines recently. The detailed molecular mechanism underlying the As(2)O(3)-induced inactivation of the cdc2 and possible functional role of PTEN in the observed G2/M arrest has yet to be elucidated. Here, we assessed the role of PTEN in regulation of As(2)O(3)-mediated G2/M cell cycle arrest in Hepatocellular carcinoma cell lines (HepG2 and SMMC7721). After 24 h following treatment, As(2)O(3) induced a concentration-dependent accumulation of cells in the G2/M phase of the cell cycle. The sustained G2/M arrest by As(2)O(3) is associated with decreased cdc2 protein and increased phospho-cdc2(Tyr15). As(2)O(3) treatment increased Wee1 levels and decreased phospho-Wee1(642). Moreover, As(2)O(3) substantially decreased the Ser473 and Thr308 phosphorylation of Akt and upregulated PTEN expression. Downregulation of PTEN by siRNA in As(2)O(3) -treated cells increased phospho-Wee1(Ser642) while decreased phospho-cdc2(Tyr15), resulting in decreased the G2/M cell cycle arrest. Therefore, induction of G2/M cell cycle arrest by As(2)O(3) involved upregulation of PTEN.
Insights
Arsenic trioxide induces G2/M cell cycle arrest in liver cancer cells by upregulating PTEN. This mechanism involves regulating cdc2 and Wee1, crucial for cell division.
Area of Science:
- Oncology
- Molecular Biology
- Cell Cycle Regulation
Background:
- Arsenic trioxide (As(2)O(3)) shows efficacy against acute promyelocytic leukemia and inhibits solid tumor cell lines.
- The molecular mechanisms of As(2)O(3)-induced G2/M arrest and the role of PTEN are not fully understood.
Purpose of the Study:
- To investigate the role of PTEN in As(2)O(3)-mediated G2/M cell cycle arrest in hepatocellular carcinoma (HCC) cell lines.
- To elucidate the molecular pathways involved in As(2)O(3) treatment in HCC.
Main Methods:
- Hepatocellular carcinoma cell lines (HepG2 and SMMC7721) were treated with As(2)O(3).
- Cell cycle progression was analyzed using flow cytometry.
- Protein levels and phosphorylation states of cdc2, Wee1, Akt, and PTEN were assessed using Western blotting.
- PTEN was downregulated using small interfering RNA (siRNA).
Main Results:
- As(2)O(3) induced a concentration-dependent G2/M phase arrest in HCC cells.
- This arrest correlated with decreased cdc2, increased phospho-cdc2(Tyr15), increased Wee1, decreased phospho-Wee1(642), decreased Akt phosphorylation, and upregulated PTEN.
- PTEN downregulation reversed the As(2)O(3)-induced G2/M arrest, affecting Wee1 and cdc2 phosphorylation.
Conclusions:
- As(2)O(3) induces G2/M cell cycle arrest in HCC cells.
- PTEN upregulation is a key mechanism in As(2)O(3)-mediated G2/M arrest.
- The pathway involves the regulation of Wee1 and cdc2 activity.
Related Concept Videos
Abnormal Proliferation
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Mutagenicity and Carcinogenicity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...